Caspian Journal of Internal Medicine
Babol University of Medical Sciences
یکشنبه 18 خرداد 1404
[Archive]
دوره 16، شماره 3 - ( 3-1404 )
جلد 16 شماره 3 صفحات 392-384 |
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
naser moghadasi A, Ebrahimi N, Bagherieh S, Mohammadi A, Sahraian M A, Ghajarzadeh M. Effect of Fampridine on cognition in patients with multiple sclerosis (MS): a systematic review and meta-analysis. Caspian J Intern Med 2025; 16 (3) :384-392
URL: http://caspjim.com/article-1-4134-fa.html
URL: http://caspjim.com/article-1-4134-fa.html
Effect of Fampridine on cognition in patients with multiple sclerosis (MS): a systematic review and meta-analysis. . 1404; 16 (3) :384-392
چکیده: (155 مشاهده)
Background: Cognitive impairment (CI) is a disabling complication in patients with multiple sclerosis (MS). Fampridine is used to improve walking abilities in subjects with MS while it is also used for improving cognition, although the results are heterogeneous. Therefore, we aimed to conduct a systematic review and meta-analysis to investigate the effect of fampridine on cognition in patients with MS.
Methods: We performed a comprehensive search in PubMed, EMBASE, Scopus, Web of Science, google scholar, and also gray including references of the references and conference abstracts on January 1th 2020. We extracted data regarding the number of participants, first author, publication year, country of origin, age, disease duration, Expanded Disability Status Scale (EDSS), duration of follow up, type of cognition test, and scores before and after the treatment.
Results: We identified 4972 studies in the preliminary search. After deduplication, 2607 articles remained. Two researchers screened the title and the abstracts, removing 2590 studies. Finally, 15 studies remained for meta-analysis. The included studies were published between 2013 and 2021, and the most frequent country of origin was Denmark. The mean age of participants of the studies ranged between 39 and 53 years and the mean EDSS ranged between 4 and 5.8, respectively. The SMD (standardized mean difference) of Symbol Digit Modalities Test (SDMT) (after-before treatment) was 0.45(95%CI: 0.06-0.84)(I2=75.3%, p<0.001). The SMD of Paced Auditory Serial Addition Test (PASAT) (after-before treatment) was 0.25 (95%CI: 0.13-0.37) (I2=84.3%, p<0.001) .
Conclusions: Fampridine has a significant role in decreasing cognitive impairments is MS patients.
Methods: We performed a comprehensive search in PubMed, EMBASE, Scopus, Web of Science, google scholar, and also gray including references of the references and conference abstracts on January 1th 2020. We extracted data regarding the number of participants, first author, publication year, country of origin, age, disease duration, Expanded Disability Status Scale (EDSS), duration of follow up, type of cognition test, and scores before and after the treatment.
Results: We identified 4972 studies in the preliminary search. After deduplication, 2607 articles remained. Two researchers screened the title and the abstracts, removing 2590 studies. Finally, 15 studies remained for meta-analysis. The included studies were published between 2013 and 2021, and the most frequent country of origin was Denmark. The mean age of participants of the studies ranged between 39 and 53 years and the mean EDSS ranged between 4 and 5.8, respectively. The SMD (standardized mean difference) of Symbol Digit Modalities Test (SDMT) (after-before treatment) was 0.45(95%CI: 0.06-0.84)(I2=75.3%, p<0.001). The SMD of Paced Auditory Serial Addition Test (PASAT) (after-before treatment) was 0.25 (95%CI: 0.13-0.37) (I2=84.3%, p<0.001) .
Conclusions: Fampridine has a significant role in decreasing cognitive impairments is MS patients.
نوع مطالعه: Review Article |
موضوع مقاله:
Neurology
دریافت: 1402/8/4 | پذیرش: 1403/3/1 | انتشار: 1404/3/20
دریافت: 1402/8/4 | پذیرش: 1403/3/1 | انتشار: 1404/3/20
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
